Regulation of nitric oxide production in hypothyroidism.

Zoran M Gluvic; Milan M Obradovic; Emina M Sudar-Milovanovic; Sonja S Zafirovic; Djordje J Radak; Magbubah M Essack; Vladimir B. Bajic; Takashi Gojobori; Esma R Isenovic

doi:10.1016/j.biopha.2020.109881

Regulation of nitric oxide production in hypothyroidism.

Zoran M Gluvic, Milan M Obradovic, Emina M Sudar-Milovanovic, Sonja S Zafirovic, Djordje J Radak, Magbubah M Essack, Vladimir B. Bajic, Takashi Gojobori, Esma R Isenovic

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Hypothyroidism is a common endocrine disorder that predominantly occurs in females. It is associated with an increased risk of cardiovascular diseases (CVD), but the molecular mechanism is not known. Disturbance in lipid metabolism, the regulation of oxidative stress, and inflammation characterize the progression of subclinical hypothyroidism. The initiation and progression of endothelial dysfunction also exhibit these changes, which is the initial step in developing CVD. Animal and human studies highlight the critical role of nitric oxide (NO) as a reliable biomarker for cardiovascular risk in subclinical and clinical hypothyroidism. In this review, we summarize the recent literature findings associated with NO production by the thyroid hormones in both physiological and pathophysiological conditions. We also discuss the levothyroxine treatment effect on serum NO levels in hypothyroid patients.

Original language	English (US)
Pages (from-to)	109881
Journal	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Volume	124
DOIs	https://doi.org/10.1016/j.biopha.2020.109881
State	Published - Jan 24 2020

Bibliographical note

KAUST Repository Item: Exported on 2020-10-01
Acknowledged KAUST grant number(s): BAS/1/1606-01-01, FCC/1/1976-17-01
Acknowledgements: This work is part of the collaboration between the Laboratory of Radiobiology and Molecular Genetics, Vinca Institute of Nuclear Sciences, University of Belgrade, Belgrade, Serbia and King Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center (CBRC), Thuwal, Saudi Arabia. This work has been supported by grants No. 173033 (E.R.I.) and No. 41002 (Dj.R.) from the Ministry of Education, Science and Technological Development, Republic of Serbia and by the KAUST grant OSR#4129 (to E.R.I. and V.B.B.), which also supported E.R.I., M.O., S.Z., and E.S.M. V.B.B. and T.G. has been supported by the KAUST Base Research FundsBAS/1/1606-01-01 and BAS/1/1059-01-01, respectively, while M.E. have been supported by the KAUST Office of Sponsored Research (OSR) grant no. FCC/1/1976-17-01.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.biopha.2020.109881

https://repository.kaust.edu.sa/bitstream/10754/661349/1/1-s2.0-S0753332220300718-main.pdf

Cite this

@article{d21177994bdb4f94b92bb138c38751b8,

title = "Regulation of nitric oxide production in hypothyroidism.",

abstract = "Hypothyroidism is a common endocrine disorder that predominantly occurs in females. It is associated with an increased risk of cardiovascular diseases (CVD), but the molecular mechanism is not known. Disturbance in lipid metabolism, the regulation of oxidative stress, and inflammation characterize the progression of subclinical hypothyroidism. The initiation and progression of endothelial dysfunction also exhibit these changes, which is the initial step in developing CVD. Animal and human studies highlight the critical role of nitric oxide (NO) as a reliable biomarker for cardiovascular risk in subclinical and clinical hypothyroidism. In this review, we summarize the recent literature findings associated with NO production by the thyroid hormones in both physiological and pathophysiological conditions. We also discuss the levothyroxine treatment effect on serum NO levels in hypothyroid patients.",

author = "Gluvic, {Zoran M} and Obradovic, {Milan M} and Sudar-Milovanovic, {Emina M} and Zafirovic, {Sonja S} and Radak, {Djordje J} and Essack, {Magbubah M} and Bajic, {Vladimir B.} and Takashi Gojobori and Isenovic, {Esma R}",

note = "KAUST Repository Item: Exported on 2020-10-01 Acknowledged KAUST grant number(s): BAS/1/1606-01-01, FCC/1/1976-17-01 Acknowledgements: This work is part of the collaboration between the Laboratory of Radiobiology and Molecular Genetics, Vinca Institute of Nuclear Sciences, University of Belgrade, Belgrade, Serbia and King Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center (CBRC), Thuwal, Saudi Arabia. This work has been supported by grants No. 173033 (E.R.I.) and No. 41002 (Dj.R.) from the Ministry of Education, Science and Technological Development, Republic of Serbia and by the KAUST grant OSR#4129 (to E.R.I. and V.B.B.), which also supported E.R.I., M.O., S.Z., and E.S.M. V.B.B. and T.G. has been supported by the KAUST Base Research FundsBAS/1/1606-01-01 and BAS/1/1059-01-01, respectively, while M.E. have been supported by the KAUST Office of Sponsored Research (OSR) grant no. FCC/1/1976-17-01.",

year = "2020",

month = jan,

day = "24",

doi = "10.1016/j.biopha.2020.109881",

language = "English (US)",

volume = "124",

pages = "109881",

journal = "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie",

issn = "0753-3322",

publisher = "Elsevier",

}

TY - JOUR

T1 - Regulation of nitric oxide production in hypothyroidism.

AU - Gluvic, Zoran M

AU - Obradovic, Milan M

AU - Sudar-Milovanovic, Emina M

AU - Zafirovic, Sonja S

AU - Radak, Djordje J

AU - Essack, Magbubah M

AU - Bajic, Vladimir B.

AU - Gojobori, Takashi

AU - Isenovic, Esma R

N1 - KAUST Repository Item: Exported on 2020-10-01 Acknowledged KAUST grant number(s): BAS/1/1606-01-01, FCC/1/1976-17-01 Acknowledgements: This work is part of the collaboration between the Laboratory of Radiobiology and Molecular Genetics, Vinca Institute of Nuclear Sciences, University of Belgrade, Belgrade, Serbia and King Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center (CBRC), Thuwal, Saudi Arabia. This work has been supported by grants No. 173033 (E.R.I.) and No. 41002 (Dj.R.) from the Ministry of Education, Science and Technological Development, Republic of Serbia and by the KAUST grant OSR#4129 (to E.R.I. and V.B.B.), which also supported E.R.I., M.O., S.Z., and E.S.M. V.B.B. and T.G. has been supported by the KAUST Base Research FundsBAS/1/1606-01-01 and BAS/1/1059-01-01, respectively, while M.E. have been supported by the KAUST Office of Sponsored Research (OSR) grant no. FCC/1/1976-17-01.

PY - 2020/1/24

Y1 - 2020/1/24

N2 - Hypothyroidism is a common endocrine disorder that predominantly occurs in females. It is associated with an increased risk of cardiovascular diseases (CVD), but the molecular mechanism is not known. Disturbance in lipid metabolism, the regulation of oxidative stress, and inflammation characterize the progression of subclinical hypothyroidism. The initiation and progression of endothelial dysfunction also exhibit these changes, which is the initial step in developing CVD. Animal and human studies highlight the critical role of nitric oxide (NO) as a reliable biomarker for cardiovascular risk in subclinical and clinical hypothyroidism. In this review, we summarize the recent literature findings associated with NO production by the thyroid hormones in both physiological and pathophysiological conditions. We also discuss the levothyroxine treatment effect on serum NO levels in hypothyroid patients.

AB - Hypothyroidism is a common endocrine disorder that predominantly occurs in females. It is associated with an increased risk of cardiovascular diseases (CVD), but the molecular mechanism is not known. Disturbance in lipid metabolism, the regulation of oxidative stress, and inflammation characterize the progression of subclinical hypothyroidism. The initiation and progression of endothelial dysfunction also exhibit these changes, which is the initial step in developing CVD. Animal and human studies highlight the critical role of nitric oxide (NO) as a reliable biomarker for cardiovascular risk in subclinical and clinical hypothyroidism. In this review, we summarize the recent literature findings associated with NO production by the thyroid hormones in both physiological and pathophysiological conditions. We also discuss the levothyroxine treatment effect on serum NO levels in hypothyroid patients.

UR - http://hdl.handle.net/10754/661349

UR - https://linkinghub.elsevier.com/retrieve/pii/S0753332220300718

UR - http://www.scopus.com/inward/record.url?scp=85078142903&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2020.109881

DO - 10.1016/j.biopha.2020.109881

M3 - Article

C2 - 31986413

SN - 0753-3322

VL - 124

SP - 109881

JO - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

JF - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

ER -

Regulation of nitric oxide production in hypothyroidism.

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this